The Journal of Immunology, Vol 146, Issue 3 865-869, Copyright © 1991 by American Association of Immunologists

ARTICLES

Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes

E Fischer, C Delibrias and MD Kazatchkine
INSERM U28, Hopital Broussais, Paris, France.

The expression of CR2 (the C3dg/EBV receptor, CD21) on normal human T lymphocytes was investigated using purified peripheral blood T cells and indirect immunofluorescence with biotinylated anti-CR2 mAb and streptavidin-phycoerythrin. Thirty to 40% of normal peripheral blood T lymphocytes expressed CR2 Ag. The cells expressed three nonoverlapping epitopes of CR2. The specificity of the staining for CR2 epitopes was demonstrated by the ability of unlabeled anti-CR2 mAb but not of anti- CR1 mAb of the same isotype to compete for the binding of biotinylated anti-CR2 mAb to T cells. The intensity of staining of T lymphocytes with anti-CR2 mAb was approximately 10-fold lower than that of peripheral blood B cells. CR2 was immunoprecipitated from purified T lymphocytes as a single protein of apparent Mr 145,000. The presence of CR2 on normal human T lymphocytes suggests that the receptor may modulate the function of T cells in the immune response and the susceptibility of the cells to infection by lymphocytotropic viruses.

This article has been cited by other articles:

				D. Liu, J.-Y. Zhu, and Z.-X. Niu Molecular Structure and Expression of Anthropic, Ovine, and Murine Forms of Complement Receptor Type 2 Clin. Vaccine Immunol., June 1, 2008; 15(6): 901 - 910. [Full Text] [PDF]

				A. Aichem, M. Masilamani, and H. Illges Redox regulation of CD21 shedding involves signaling via PKC and indicates the formation of a juxtamembrane stalk J. Cell Sci., July 15, 2006; 119(14): 2892 - 2902. [Abstract] [Full Text] [PDF]

				D. H. Dreyfus, A. J. Gross, and D. Thorley-Lawson Role of T Cells in EBV-Infected Systemic Lupus Erythematosus Patients J. Immunol., September 15, 2005; 175(6): 3460 - 3461. [Full Text] [PDF]

				M. Tolnay, L. A. Vereshchagina, and G. C. Tsokos NF-{kappa}B Regulates the Expression of the Human Complement Receptor 2 Gene J. Immunol., December 1, 2002; 169(11): 6236 - 6243. [Abstract] [Full Text] [PDF]

				P. Trempat, J. Tabiasco, P. Andre, N. Faumont, F. Meggetto, G. Delsol, R. D. Gascoyne, J.-J. Fournie, E. Vivier, and P. Brousset Evidence for Early Infection of Nonneoplastic Natural Killer Cells by Epstein-Barr Virus J. Virol., October 2, 2002; 76(21): 11139 - 11142. [Abstract] [Full Text] [PDF]

				C. H. Nielsen and R. G. Q. Leslie Complement's participation in acquired immunity J. Leukoc. Biol., August 1, 2002; 72(2): 249 - 261. [Abstract] [Full Text] [PDF]

				D. Ulgiati and V. M. Holers CR2/CD21 Proximal Promoter Activity Is Critically Dependent on a Cell Type-Specific Repressor J. Immunol., December 15, 2001; 167(12): 6912 - 6919. [Abstract] [Full Text] [PDF]

				Y. Kasahara, A. Yachie, K. Takei, C. Kanegane, K. Okada, K. Ohta, H. Seki, N. Igarashi, K. Maruhashi, K. Katayama, et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection Blood, September 15, 2001; 98(6): 1882 - 1888. [Abstract] [Full Text] [PDF]

				J. Schwab and H. Illges Regulation of CD21 expression by DNA methylation and histone deacetylation Int. Immunol., May 1, 2001; 13(5): 705 - 710. [Abstract] [Full Text] [PDF]

				K. J. Marchbank, C. C. Watson, D. F. Ritsema, and V. M. Holers Expression of Human Complement Receptor 2 (CR2, CD21) in Cr2-/- Mice Restores Humoral Immune Function J. Immunol., September 1, 2000; 165(5): 2354 - 2361. [Abstract] [Full Text] [PDF]

				E. M. Fischer, A. Mouhoub, F. Maillet, V. Fremeaux-Bacchi, C. Krief, H. Gould, S. Berrih-Aknin, and M. D. Kazatchkine Expression of CD21 is developmentally regulated during thymic maturation of human T lymphocytes Int. Immunol., November 1, 1999; 11(11): 1841 - 1849. [Abstract] [Full Text] [PDF]

				W. M. Prodinger, M. G. Schwendinger, J. Schoch, M. Kochle, C. Larcher, and M. P. Dierich Characterization of C3dg Binding to a Recess Formed Between Short Consensus Repeats 1 and 2 of Complement Receptor Type 2 (CR2; CD21) J. Immunol., November 1, 1998; 161(9): 4604 - 4610. [Abstract] [Full Text] [PDF]

				K. W. Makar, C. T. N. Pham, M. H. Dehoff, S. M. O'Connor, S. M. Jacobi, and V. M. Holers An Intronic Silencer Regulates B Lymphocyte Cell- and Stage-Specific Expression of the Human Complement Receptor Type 2 (CR2, CD21) Gene J. Immunol., February 1, 1998; 160(3): 1268 - 1278. [Abstract] [Full Text] [PDF]

				H. Groux, F. Cottrez, C. Montpellier, B. Quatannens, J. Coll, D. Stehelin, and C. Auriault Isolation and Characterization of Transformed Human T-Cell Lines Infected by Epstein-Barr Virus Blood, June 15, 1997; 89(12): 4521 - 4530. [Abstract] [Full Text] [PDF]

				L Flores-Romo, J Shields, Y Humbert, P Graber, J. Aubry, J. Gauchat, G Ayala, B Allet, M Chavez, H Bazin, et al. Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23 Science, August 20, 1993; 261(5124): 1038 - 1041. [Abstract] [PDF]